Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
04/2002
04/18/2002US20020045183 Methods for detecting mutations using primer extension
04/18/2002US20020045182 Multiplexed differential displacement for nucleic acid determinations
04/18/2002US20020045181 Method for displaying result of hybridization experiment using biochip and method for evaluating experimental error of hybridization experiment
04/18/2002US20020045180 Useful as substrates for polymerase enzymes; used in preparing fluorescently-labeled nucleotides useful as substrates for thermostable polymerases
04/18/2002US20020045179 Generating chemical profile in cells; obtain mammalian cells, incubate with chemical intermediate, monitor adjustments in gene and protein expression, generate profile
04/18/2002US20020045178 Use of nucleotide analogs in the analysis of oligonucleotide mixtures and in highly multiplexed nucleic acid sequencing
04/18/2002US20020045177 Cloning preferential genes; obtain cells, transform, express preferential genes in cells, monitor activity of genes in biosynthetic process
04/18/2002US20020045176 Analyzing blood sample from pregnant human; obtain blood, remove cells, recover nucleotide sequences, determine genetic profile of fetus
04/18/2002US20020045174 Gene sequencer and method for determining the nucleotide sequence of a chromosome
04/18/2002US20020045171 Method of profiling genes as risk factors for attention deficit hyperactivity disorder
04/18/2002US20020045169 Detecting preferential exons within genomes; obtain sample, incubate with probes, detect hybridization in genome, map binding profile
04/18/2002US20020045167 Used for detecting incomplete deprotection of a synthetic oligonucleotide by immunoassay
04/18/2002US20020045166 Peptides; for use as tools in gene therapy
04/18/2002US20020045165 Detecting target nucleotide sequences in sample; obtain sample, incubate sample with preferential nucleotides, detect bound sequences, classify sample
04/18/2002US20020045164 Reagents and methods useful for detecting diseases of the lung
04/18/2002US20020045163 Method for using unequal primer concentrations for generating nucleic acid amplification products
04/18/2002US20020045162 Identification of viral agents in breast ducts and antiviral therapy therefore
04/18/2002US20020045158 Cells for drug discovery
04/18/2002US20020044946 12-25 kDa bacterial proteins and their 116-58 kDa polymers useful in anti-tumor vaccines
04/18/2002US20020044893 Made using a reversible protecting group to reversibly modify omega-functionalized alkanethiols self-assembled on metal substrates, and immobilizing cells or biomolecules; use in surface plasmon resonance (SPR) imaging
04/18/2002US20020044885 Device and method for photoactivation
04/18/2002US20020044656 Interfacing a conditional access circuit to a digital device using input and output stream switching
04/18/2002US20020043471 Device and method for determining the concentration of a substrate
04/18/2002DE10050942A1 Detecting cytosine methylation in genomic DNA, useful e.g. for disease diagnosis and prognosis, comprises conversion of unmethylated cytosine to uracil then amplification
04/18/2002DE10050361A1 Statistical processing of gene sequences to determine possible haplotypes and their probability, useful e.g. for identifying genetic origins of complex diseases
04/18/2002DE10050135A1 Verfahren zur Sterilitätsprüfung von insbesondere flüssigen Medien A method for sterility testing of particular liquid media
04/18/2002DE10049074A1 Verfahren zur Selektion hochaffin an ein Target bindender Nukleinsäuren A method for selecting high affinity to a target nucleic acids binding
04/18/2002DE10048944A1 Verfahren zur Selektion hochaffin an ein Target bindender Nukleinsäuren durch zweidimensionale Auftrennung A method for selecting high affinity to a target nucleic acids binding by two-dimensional separation
04/18/2002DE10048633A1 Methode zur in vitro Diagnostik von Endometriose Method for in vitro diagnosis of endometriosis
04/18/2002DE10047794A1 New RNA-cleaving polyaza-cycloalkane complex, useful e.g. in medical genetics, preferentially cleaves after an unpaired uridine
04/18/2002DE10045808A1 Verfahren zur Detektion der Aktivität von Wirkstoffen A method for detection of the activity of active ingredients
04/18/2002CA2811096A1 Enhanced selection of genetically modified pine embryogenic tissue
04/18/2002CA2499349A1 Methods for raising pre-adult anadromous fish
04/18/2002CA2462758A1 Diagnostic indicator of thymic function
04/18/2002CA2461990A1 Method and apparatus for the in-situ preparation of macromolecules via uniform glow discharge plasma
04/18/2002CA2425917A1 Artificial transcriptional factors and methods of use
04/18/2002CA2425818A1 Novel human beta2 integrin alpha subunit
04/18/2002CA2425806A1 Methods for detecting modulators of ion channels using thallium (i) sensitive assays
04/18/2002CA2425767A1 Lipocalins
04/18/2002CA2425671A1 Human ect2 and methods of use
04/18/2002CA2425643A1 Cancer-linked genes as targets for chemotherapy
04/18/2002CA2425610A1 Intracellular delivery of biological effectors by novel transporter peptide sequences
04/18/2002CA2425593A1 Uridine therapy for patients with elevated purine levels
04/18/2002CA2425569A1 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
04/18/2002CA2425545A1 Methods of identification and isolation of polynucleotides containing nucleic acid differences
04/18/2002CA2425488A1 Interactive correlation of compound information and genomic information
04/18/2002CA2425434A1 Methods for characterizing molecular interactions using affinity capture tandem mass spectrometry
04/18/2002CA2425413A1 System and method for determining the presence of methylated cytosines in polynucleotides
04/18/2002CA2425412A1 Nanoscale sensor
04/18/2002CA2425366A1 Method for the detection of cytosine methylations
04/18/2002CA2425356A1 Hedgehog antagonists, methods and uses related thereto
04/18/2002CA2425302A1 Novel polypeptides homologous to thymosin, ephrin a, receptors, and fibromodulin, and polynucleotides encoding same
04/18/2002CA2425298A1 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
04/18/2002CA2425293A1 A novel system for the evaluation of the activity and/or specificity of a viral component
04/18/2002CA2425001A1 Novel serine protease genes related to dppiv
04/18/2002CA2424998A1 Nucleic acid integration assay
04/18/2002CA2424983A1 Nucleic acid molecules and polypeptides for immune modulation
04/18/2002CA2424947A1 Surface adsorbing polymers and the uses thereof to treat hydrophobic or hydrophilic surfaces
04/18/2002CA2424856A1 Specific double-stranded probes for homogeneous detection of nucleic acid and their application methods
04/18/2002CA2424821A1 Gene encoding a human g-protein coupled receptor and its use
04/18/2002CA2424791A1 Detection of the presence of a microbe or related substance at a location
04/18/2002CA2424435A1 Dendritically amplified detection method
04/18/2002CA2424317A1 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products
04/18/2002CA2423552A1 High throughput processing system and method of using
04/18/2002CA2393374A1 High throughput or capillary-based screening for a bioactivity or biomolecule
04/17/2002EP1197749A1 Biosensor
04/17/2002EP1197568A2 Detection and typing of HCV using 5'UTR and NS5 nucleic acid sequences
04/17/2002EP1197567A2 Characterisation of gene function using double stranded RNA inhibition
04/17/2002EP1197566A2 Method for testing the sterility of liquid media
04/17/2002EP1197565A1 A novel point mutation in the 3'region of the prothrombin gene associated with increased risk of thrombosis
04/17/2002EP1197564A1 Method of pretreatment of sample for quantitating cholesterol and method for quantitating cholesterol in specific lipoproteins by using the same
04/17/2002EP1197551A1 Dna chip
04/17/2002EP1197550A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis
04/17/2002EP1197143A1 Goodpasture's syndrome model mouse
04/17/2002EP1196783A2 Screening for therapeutic agents being scap antagonists
04/17/2002EP1196782A1 Catalytic anti-factor viii allo-antibodies
04/17/2002EP1196781A2 Method of diagnosis of cardiac hypertrophy
04/17/2002EP1196779A1 Determining antibodies to ny-eso-1 in cancer patients
04/17/2002EP1196778A1 Method and kit for immuno-detecting bacteria in blood and tissues
04/17/2002EP1196777A1 Rapid test employing an adhesive slide
04/17/2002EP1196776A1 Fluorescent intensity method for assaying binding between proteins or peptides
04/17/2002EP1196773A1 E4orf4 and pp2a polypeptides, modulators, and mimetics for selectively inducing cell death
04/17/2002EP1196772A2 Induction of a th1-like response in vitro
04/17/2002EP1196767A1 Polymeric compositions and sensor devices
04/17/2002EP1196755A1 Genetic assay system
04/17/2002EP1196640A2 Electron-deficient nitrogen heterocycle-substituted fluorescein dyes
04/17/2002EP1196639A2 A method for amplifying low abundance nucleic acid sequences and means for performing said method
04/17/2002EP1196638A1 USE OF THE i KRIT1 /i GENE IN ANGIOGENESIS
04/17/2002EP1196636A1 Spatially-encoded analyte detection
04/17/2002EP1196635A2 Cell death related drug targets in yeast and fungi
04/17/2002EP1196634A1 Method for identifying a compound that modulates the function of the gene product of an essential gene
04/17/2002EP1196633A2 Methods and compositions for performing array based hybridization assays
04/17/2002EP1196632A2 Multiple tag analysis
04/17/2002EP1196631A1 Polynucleotides
04/17/2002EP1196630A2 Detection of nucleic acid reactions on bead arrays
04/17/2002EP1196629A2 High resolution dna detection methods and devices
04/17/2002EP1196628A2 Method and sample support system for separating and processing substances in situ
04/17/2002EP1196627A2 Gene chip technology for determining memory genes
04/17/2002EP1196626A2 Methods for identifying inhibitors of signaling molecules
04/17/2002EP1196625A1 Composition and method for detecting and early and differentiated counting of gram-negative microorganisms